HB1312 CR 4.28.2026 EDA — Senate Committee Report

New Bill Status Search

STATE OF NEW HAMPSHIRE

 

SENATE

 

REPORT OF THE COMMITTEE

FOR THE CONSENT CALENDAR

 

Tuesday, April 28, 2026

 

THE COMMITTEE ON Executive Departments and Administration

 

to which was referred HB 1312

 

AN ACT relative to the authority of various boards.

 

 

Having considered the same, the committee recommends that the Bill

 

OUGHT TO PASS WITH AMENDMENT

 

BY A VOTE OF: 5-0

 

AMENDMENT # 2026-1637s

 

 

Senator Howard Pearl

For the Committee

 

HB 1312 concerns the authority of boards under the Office of Professional Licensure and Certification. It authorizes these boards to establish subcommittees, subject to OPLC rules. It also removes the authority of boards of registration in optometry to modify the list of approved pharmaceuticals used by optometrists and removes the board of accountancy’s authority to establish fines by rule. As amended, the bill allows optometry boards to update the approved pharmaceuticals list when updating formularies, moves approval of medical imaging and radiation therapy programs to the OPLC executive director (with advisory input from the board of medical imaging and radiation therapy), and adjusts duties and authority of the family mediator certification board.

 

Ben Mickens  271-1403

 

FOR THE CONSENT CALENDAR

 

Executive Departments and Administration

HB 1312, relative to the authority of various boards.

Ought to Pass with Amendment, Vote 5-0.

Senator Howard Pearl for the committee.

HB 1312 concerns the authority of boards under the Office of Professional Licensure and Certification. It authorizes these boards to establish subcommittees, subject to OPLC rules. It also removes the authority of boards of registration in optometry to modify the list of approved pharmaceuticals used by optometrists and removes the board of accountancy’s authority to establish fines by rule. As amended, the bill allows optometry boards to update the approved pharmaceuticals list when updating formularies, moves approval of medical imaging and radiation therapy programs to the OPLC executive director (with advisory input from the board of medical imaging and radiation therapy), and adjusts duties and authority of the family mediator certification board.